AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1405328 — intervention group
Group type: EXPERIMENTAL
Intervention: Flat plate (FP) dialyzer
Number of subjects: 12
Study 1405328 — intervention group
Group type: EXPERIMENTAL
Intervention: Hollow fiber (HF) dialyzer
Number of subjects: 12
Study 1405328 — intervention group
Group type: COMPARATOR
Intervention: EPO therapy
Number of subjects: 12
Study 1405328 — intervention group
Group type: COMPARATOR
Intervention: Both dialyzer types (FP and HF)
Number of subjects: 12
Study 3882371 — intervention group
Group type: EXPERIMENTAL
Intervention: New device for giving multiple injections of short‐acting insulin
Number of subjects: 16
Study 3882371 — intervention group
Group type: COMPARATOR
Intervention: Conventional syringes for injections of short‐acting insulin
Number of subjects: 16
Study 31258128 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg
Number of subjects: 0
Study 31258128 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 30 mg
Number of subjects: 0
Study 31258128 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate
Number of subjects: 0
Study 29331343 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation stent
Number of subjects: 328
Study 29331343 — intervention group
Group type: COMPARATOR
Intervention: Uncovered self-expandable metallic stent (SEMS)
Number of subjects: 328
Study 27468542 — intervention group
Group type: EXPERIMENTAL
Intervention: Qingxue Dan (QXD) 900 mg/d for 8 weeks
Number of subjects: 26
Study 27468542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 24509284 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermia induced by rapid infusion of 600 to 2,000 ml cold saline and endovascular cooling
Number of subjects: 120
Study 24509284 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 120
Study 24509284 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermia
Number of subjects: 120
Study 23057611 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile dry cupping (8 sessions within 4 weeks)
Number of subjects: 40
Study 23057611 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 40
Study 21252603 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-based exercise program (n=30)
Number of subjects: 60
Study 21252603 — intervention group
Group type: COMPARATOR
Intervention: Home-based exercise program (n=30)
Number of subjects: 60
Study 17556425 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 l fill of dialysate
Number of subjects: 15
Study 17556425 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 l fill of dialysate
Number of subjects: 15
Study 16224653 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic operation
Number of subjects: 60
Study 16224653 — intervention group
Group type: COMPARATOR
Intervention: Open operation
Number of subjects: 60
Study 11942049 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent maintenance chemotherapy
Number of subjects: 25
Study 11942049 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 25
Study 9467547 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg daily
Number of subjects: 111
Study 9467547 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg cyclic
Number of subjects: 111
Study 9467547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 9467547 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg daily and cyclic
Number of subjects: 111
Study 9467547 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 111
Study 7637185 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine (DOA)
Number of subjects: 24
Study 7637185 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1)
Number of subjects: 24
Study 7637185 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 2529410 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol solution (0.5 g ethanol/kg B.Wt.)
Number of subjects: 0
Study 2529410 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 0
Study 676644 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous naloxone (0.04 mg increments every 3 min) until ET(CO2) < 8% (group I)
Number of subjects: 60
Study 676644 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous naloxone (0.04 mg increments every 3 min) until ET(CO2) < 6.5% (group II)
Number of subjects: 60
Study 676644 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous naloxone (0.04 mg increments every 3 min) + additional intramuscular naloxone (group III)
Number of subjects: 60
Study 676644 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous naloxone (0.04 mg increments every 3 min) + additional intramuscular naloxone (group IV)
Number of subjects: 60
Study 30620614 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 Hz NMES
Number of subjects: 16
Study 30620614 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz NMES
Number of subjects: 16
Study 30620614 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 Hz NMES
Number of subjects: 16
Study 30620614 — intervention group
Group type: COMPARATOR
Intervention: 10 Hz and 50 Hz NMES
Number of subjects: 16
Study 28087725 — intervention group
Group type: EXPERIMENTAL
Intervention: High PCO2 target
Number of subjects: 359
Study 28087725 — intervention group
Group type: COMPARATOR
Intervention: Control group with mildly elevated PCO2 targets
Number of subjects: 359
Study 26159018 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic shape bracket splints
Number of subjects: 60
Study 26159018 — intervention group
Group type: COMPARATOR
Intervention: Common splints
Number of subjects: 60
Study 24347520 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term psychodynamic psychotherapy (STPP)
Number of subjects: 157
Study 24347520 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 157
Study 21244446 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra‐articular 70% ethyl alcohol alone (IAEA)
Number of subjects: 6
Study 21244446 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra‐articular 70% ethyl alcohol in combination with 2 percutaneously placed transarticular lag screws (EA‐TLS)
Number of subjects: 6
Study 19178123 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous interferon-beta-1a (SC IFNb1a) administered three times a week
Number of subjects: 1000
Study 19178123 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular interferon-beta-1a (IM IFNb1a) administered once a week
Number of subjects: 1000
Study 19178123 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous interferon-beta-1a (SC IFNb1a)
Number of subjects: 1000
Study 19178123 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular interferon-beta-1a (IM IFNb1a)
Number of subjects: 1000
Study 17705694 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (1 year administration)
Number of subjects: 22
Study 17705694 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (no intervention)
Number of subjects: 22
Study 15800754 — intervention group
Group type: EXPERIMENTAL
Intervention: Midvastus approach
Number of subjects: 21
Study 15800754 — intervention group
Group type: COMPARATOR
Intervention: Medial parapatellar approach
Number of subjects: 21
Study 12481955 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional acupuncture
Number of subjects: 593
Study 12481955 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula acupuncture
Number of subjects: 593
Study 12481955 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 593
Study 12481955 — intervention group
Group type: COMPARATOR
Intervention: No acupuncture
Number of subjects: 593
Study 9579104 — intervention group
Group type: EXPERIMENTAL
Intervention: Single broadband noise signal from a subset of six loudspeakers
Number of subjects: 0
Study 9579104 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of pairs of speakers that were symmetrically opposed
Number of subjects: 0
Study 8620673 — intervention group
Group type: EXPERIMENTAL
Intervention: Zileuton (600mg every 6 hours)
Number of subjects: 24
Study 8620673 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 2669904 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl
Number of subjects: 40
Study 2669904 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 1191616 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric drill removal
Number of subjects: 0
Study 1191616 — intervention group
Group type: COMPARATOR
Intervention: Manual removal
Number of subjects: 0
Study 31317523 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist‐oriented home rehabilitation (TOHR)
Number of subjects: 17
Study 27834460 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconia-on-polyethylene (group A)
Number of subjects: 393
Study 27834460 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal-on-metal (group B)
Number of subjects: 393
Study 27834460 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconia-on-polyethylene with the liner moulded into the shell (group C)
Number of subjects: 393
Study 27834460 — intervention group
Group type: EXPERIMENTAL
Intervention: Alumina-on-alumina (group D)
Number of subjects: 393
Study 25670536 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 15
Study 25670536 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine
Number of subjects: 15
Study 25670536 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolasetron
Number of subjects: 15
Study 25670536 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 15
Study 25670536 — intervention group
Group type: EXPERIMENTAL
Intervention: Dofetilide
Number of subjects: 15
Study 25670536 — intervention group
Group type: COMPARATOR
Intervention: Levocetirizine
Number of subjects: 15
Study 23218821 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotenoids with Coantioxidants (lutein, zeaxanthin, vitamin C, vitamin E, copper, and zinc)
Number of subjects: 433
Study 23218821 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 433
Study 21777702 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypill containing 75 mg aspirin, 40 mg simvastatin, 10 mg lisinopril, and either 12.5 mg hydrochlorothiazide or 50 mg atenolol
Number of subjects: 600
Study 21777702 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 600
Study 19396428 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment (surgical release of the internal obturator tendon)
Number of subjects: 12
Study 19396428 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-operative treatment)
Number of subjects: 12
Study 19396428 — intervention group
Group type: EXPERIMENTAL
Intervention: Degenerative changes at L3-L5 level
Number of subjects: 12
Study 17007709 — intervention group
Group type: EXPERIMENTAL
Intervention: Team-based continuous quality improvement (CQI) intervention
Number of subjects: 49
Study 17007709 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49
Study 15497363 — intervention group
Group type: EXPERIMENTAL
Intervention: +45 mmHg LBPP
Number of subjects: 6
Study 15497363 — intervention group
Group type: EXPERIMENTAL
Intervention: -20 mmHg LBNP
Number of subjects: 6
Study 15497363 — intervention group
Group type: COMPARATOR
Intervention: No pressure (Control)
Number of subjects: 6
Study 12823077 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine CR (100 to 300 mg once daily for 12 weeks)
Number of subjects: 253
Study 12823077 — intervention group
Group type: COMPARATOR
Intervention: Placebo (once daily for 12 weeks)
Number of subjects: 253
Study 12823077 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine CR
Number of subjects: 253
Study 10221739 — intervention group
Group type: EXPERIMENTAL
Intervention: Research Assistants (RAs)
Number of subjects: 347
Study 10221739 — intervention group
Group type: COMPARATOR
Intervention: Senior Investigators (SI)
Number of subjects: 347
Study 7784236 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (digitalis, diuretics, and vasodilators) for 8.1 +/- 0.7 months (Control)
Number of subjects: 68
Study 7784236 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional therapy plus prednisone
Number of subjects: 68
Study 7784236 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional therapy plus prednisone and azathioprine
Number of subjects: 68
Study 7784236 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional therapy plus prednisone and cyclosporine
Number of subjects: 68
Study 2360388 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 84
Study 2360388 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate
Number of subjects: 84
Study 2360388 — intervention group
Group type: COMPARATOR
Intervention: Intravenous saline (control)
Number of subjects: 84
Study 222145 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinyl alcohol tartrate (Roniacol)
Number of subjects: 19
Study 222145 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofibrate (Atromid‐S)
Number of subjects: 19
Study 222145 — intervention group
Group type: COMPARATOR
Intervention: Both drugs
Number of subjects: 19
Study 28662153 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily physiotherapy with progressive knee‐extension strength training (10RM), 3 x 10 repetitions, of the fractured limb using ankle weight cuffs.
Number of subjects: 90
Study 28662153 — intervention group
Group type: COMPARATOR
Intervention: Daily physiotherapy without strength training.
Number of subjects: 90
Study 25844612 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin phosphate 1.2%/BP 3.75% gel
Number of subjects: 498
Study 25844612 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 498
Study 23586591 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifonazole 1% cream for 4 weeks after non-surgical nail ablation with urea 40% paste
Number of subjects: 692
Study 23586591 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 4 weeks after non-surgical nail ablation with urea 40% paste
Number of subjects: 692
Study 23586591 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifonazole 1% cream
Number of subjects: 692
Study 23586591 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 692
Study 22005390 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial fibrillation (AF) patients
Number of subjects: 2865
Study 19252210 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple rule-of-thumb (RoT) algorithms (3 lbs in 1 day and 5 lbs in 3 days)
Number of subjects: 168
Study 19252210 — intervention group
Group type: COMPARATOR
Intervention: Moving average convergence divergence (MACD) algorithm
Number of subjects: 168
Study 16881474 — intervention group
Group type: EXPERIMENTAL
Intervention: transrectal lidocaine gel
Number of subjects: 240
Study 16881474 — intervention group
Group type: EXPERIMENTAL
Intervention: quadrant lidocaine injections
Number of subjects: 240
Study 16881474 — intervention group
Group type: EXPERIMENTAL
Intervention: apex‐only lidocaine injections
Number of subjects: 240
Study 16881474 — intervention group
Group type: COMPARATOR
Intervention: no local anesthetic
Number of subjects: 240
Study 15599319 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 1.5 mg/day
Number of subjects: 588
Study 15599319 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 3 mg/day
Number of subjects: 588
Study 15599319 — intervention group
Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF) 2 g/day
Number of subjects: 588
Study 11728761 — intervention group
Group type: EXPERIMENTAL
Intervention: BiPAP
Number of subjects: 38
Study 11728761 — intervention group
Group type: COMPARATOR
Intervention: MASK
Number of subjects: 38
Study 9205018 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 274
Study 9205018 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274
Study 7957138 — intervention group
Group type: EXPERIMENTAL
Intervention: Squat technique
Number of subjects: 10
Study 7957138 — intervention group
Group type: COMPARATOR
Intervention: Stoop technique
Number of subjects: 10
Study 7957138 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 10
Study 30061029 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 doses of MenABCWY vaccine (0, 2, 6-month schedule)
Number of subjects: 490
Study 30061029 — intervention group
Group type: COMPARATOR
Intervention: Single MenACWY-CRM dose at 2 months and placebo at 0, 6 months (Control group)
Number of subjects: 490
Study 25139979 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral cysteine-HCl (CYS group) at 121 mg/kg/d for ≥7 days
Number of subjects: 38
Study 25139979 — intervention group
Group type: COMPARATOR
Intervention: Additional PN amino acids (ISO group)
Number of subjects: 38
Study 23866315 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (SSRI), 4-week intervention
Number of subjects: 0
Study 23866315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 21712498 — intervention group
Group type: COMPARATOR
Intervention: rosuvastatin (10 mg/day)
Number of subjects: 12
Study 21712498 — intervention group
Group type: COMPARATOR
Intervention: darunavir/ritonavir (600/100 mg twice daily)
Number of subjects: 12
Study 21712498 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of darunavir/ritonavir and rosuvastatin
Number of subjects: 12
Study 19716434 — intervention group
Group type: EXPERIMENTAL
Intervention: Transparent retractable extension
Number of subjects: 107
Study 19716434 — intervention group
Group type: COMPARATOR
Intervention: Narrow band imaging
Number of subjects: 107
Study 18279940 — intervention group
Group type: COMPARATOR
Intervention: Intermittent Androgen Deprivation (IAD) therapy with bicalutamide 150 mg once daily in on-phases and no therapy in off-phases (Group A)
Number of subjects: 44
Study 18279940 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Androgen Deprivation (IAD) therapy with bicalutamide 150 mg once daily in on-phases and etoricoxib 60 mg once daily in off-phases (Group B)
Number of subjects: 44
Study 18279940 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (IAD with etoricoxib)
Number of subjects: 44
Study 18279940 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study 15930233 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal transfusion group
Number of subjects: 100
Study 15930233 — intervention group
Group type: COMPARATOR
Intervention: Restrictive transfusion group
Number of subjects: 100
Study 12538198 — intervention group
Group type: EXPERIMENTAL
Intervention: Incisional local anesthetic infiltration plus postoperative patient‐controlled analgesia (Group A)
Number of subjects: 114
Study 12538198 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia and analgesia (Group B)
Number of subjects: 114
Study 12538198 — intervention group
Group type: COMPARATOR
Intervention: Postoperative patient‐controlled analgesia (Group C)
Number of subjects: 114
Study 11776031 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with cyclophosphamide 300 mg/m2, vincristine 1.4 mg/m2, adriamycin 50 mg/m2, lomustine 50 mg/m2 on day 1, and cisplatin 20 mg/m2 on days 1-5, repeated every 4-6 weeks for 4 cycles, followed by oral ftorafur (FT-207) 600-900 mg/d for 1 year
Number of subjects: 70
Study 11776031 — intervention group
Group type: COMPARATOR
Intervention: Surgery only
Number of subjects: 70
Study 11776031 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with cyclophosphamide, vincristine, adriamycin, lomustine, and cisplatin
Number of subjects: 70
Study 8858224 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion (serum free insulin approximately 480 pmol/l)
Number of subjects: 15
Study 8858224 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (physiological NaCl solution)
Number of subjects: 15
Study 8858224 — intervention group
Group type: COMPARATOR
Intervention: Comparison of insulin infusion vs saline infusion
Number of subjects: 15
Study 1634647 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicoderm (nicotine transdermal system) 14 mg/day applied to upper back
Number of subjects: 12
Study 1634647 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicoderm (nicotine transdermal system) 14 mg/day applied to upper outer arm
Number of subjects: 12
Study 1634647 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicoderm (nicotine transdermal system) 14 mg/day applied to upper chest
Number of subjects: 12
Study 6545087 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal analgesia
Number of subjects: 26
Study 6545087 — intervention group
Group type: COMPARATOR
Intervention: Non-caudal group (Control)
Number of subjects: 26
Study 31002483 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentalization-based group intervention
Number of subjects: 64
Study 31002483 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment
Number of subjects: 64
Study 29523823 — intervention group
Group type: EXPERIMENTAL
Intervention: QuickOpt
Number of subjects: 392
Study 29523823 — intervention group
Group type: COMPARATOR
Intervention: Echocardiographic optimization (control)
Number of subjects: 392
Study 27388012 — intervention group
Group type: EXPERIMENTAL
Intervention: G6PD heterozygous (type A+)
Number of subjects: 301
Study 27388012 — intervention group
Group type: EXPERIMENTAL
Intervention: G6PD deficient (type A-)
Number of subjects: 301
Study 27388012 — intervention group
Group type: COMPARATOR
Intervention: G6PD normal (type B)
Number of subjects: 301
Study 24973281 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumacaftor 200 mg once daily and ivacaftor 250 mg every 12 h for 14 days followed by 7 days of ivacaftor or 21 days of placebo
Number of subjects: 188
Study 24973281 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumacaftor 400 mg once daily
Number of subjects: 188
Study 24973281 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumacaftor 600 mg once daily
Number of subjects: 188
Study 24973281 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumacaftor 400 mg every 12 h
Number of subjects: 188
Study 24973281 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study 22119354 — intervention group
Group type: EXPERIMENTAL
Intervention: gemcitabine plus erlotinib
Number of subjects: 569
Study 22119354 — intervention group
Group type: COMPARATOR
Intervention: gemcitabine
Number of subjects: 569